Acquired bartter-like syndrome associated with gentamicin administration

American Journal of the Medical Sciences

Volumn 329, Issue 3, 2005, Pages 144-149

  Chou, Chu Lin ^a   Chen, Yeong Hwang ^a   Chau, Tom ^a   Lin, Shih Hua ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Aminoglycosides; Bartter syndrome; Gentamicin; Hypokalemia; Hypomagnesemia

Indexed keywords

CALCIUM SENSING RECEPTOR; CEFALOTIN; CITRATE CALCIUM; GENTAMICIN; GLUCONATE CALCIUM; MAGNESIUM OXIDE; MAGNESIUM SULFATE; METRONIDAZOLE; PARATHYROID HORMONE; POTASSIUM CHLORIDE;

ADULT; AGED; ANAMNESIS; APPENDECTOMY; APPENDICITIS; ARTICLE; BARTTER SYNDROME; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; HYPOCALCEMIA; HYPOMAGNESEMIA; LABORATORY TEST; METABOLIC ALKALOSIS; PARATHYROID HORMONE BLOOD LEVEL; TETANY; TREATMENT WITHDRAWAL;

EID: 14844361715     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200503000-00007     Document Type: Article

References (31)

1. Bennett WM, Pulliam JP, Porter GA, et al. Modification of experimental gentamicin nephrotoxicity by selective parathyroidectomy. Am J Physiol 1985;249:832-5.
2. Bar RS, Wilson HE, Mazzaferri EL. Hypomagnesemic hypocalcemia secondary to renal magnesium wasting. Ann Intern Med 1975;82:646-9.
3. Kelnar CJ, Taor WS, Reynolds DJ, et al. Hypomagnesaemic hypocalcaemia with hypokalaemia caused by treatment with high dose gentamicin. Arch Dis Child 1978;53:817-20.
4. Kourilsky O, Solez K, Morel-Maroger L, et al. The pathology of acute renal failure due to interstitial nephritis in man with comments on the role of interstitial inflammation and sex in gentamicin nephrotoxicity. Medicine 1982;61:258-68.
5. Seguro AC, Shimizu MH, Monteiro JL, et al. Effect of potassium depletion on ischemic renal failure. Nephron 1989;51:350-4.
6. Holmes AM, Hesling CM, Wilson TM. Drug-induced secondary hyperaldosteronism in patients with pulmonary tuberculosis. Q J Med 1970;39:299-315.
7. Schwartz JH, Schein P. Fanconi syndrome associated with cephalothin and gentamicin therapy. Cancer 1978;41:769-72.
8. Keating MJ, Sethi MR, Bodey GP, et al. Hypocalcemia with hypoparathyroidism and renal tubular dysfunction associated with aminoglycoside therapy. Cancer 1977;39:1410-4.
9. Russo JC, Adelman RD. Gentamicin-induced Fanconi syndrome. J Pediatr 1980;96:151-3.
10. Alexandridis G, Liberopoulos E, Elisaf M. Aminoglycoside-induced reversible tubular dysfunction. Pharmacology 2003;67:118-20.
11. Fuchs S, Kaminski N, Brezis M. Metabolic abnormality induced by streptomycin. BMJ 1994;309:512.
12. Goodhart GL, Handelsman S. Gentamicin and hypokalemia. Ann Intern Med 1985;103:645-6.
13. Landau D, Kher KK. Gentamicin-induced Bartter-like syndrome. Pediatr Nephrol 1997;11:737-40.
14. Nanji AA, Denegri JF. Hypomagnesemia associated with gentamicin therapy. Drug Intell Clin Pharm 1984;18:596-8.
15. Patel R, Savage A. Symptomatic hypomagnesemia associated with gentamicin therapy. Nephron 1979;23:50-2.
16. Shiah CJ, Tsai DM, Liao ST, et al. Acute muscular paralysis in an adult with subclinical Bartter's syndrome associated with gentamicin administration. Am J Kidney Dis 1994; 24:932-5.
17. Shetty AK, Rogers NL, Mannick EE, et al. Syndrome of hypokalemic metabolic alkalosis and hypomagnesemia associated with gentamicin therapy: case reports. Clin Pediatr 2000;39:529-33.
18. Slayton W, Anstine D, Lakhdir F, et al. Tetany in a child with AIDS receiving intravenous tobramycin. South Med J 1996;89:1108-10.
19. Tezic T, Saraclar Y, Bilginturan N, et al. Symptomatic hypocalcemia and hypomagnesemia due to gentamicin therapy in an 8-year-old girl. Turk J Pediatr 1982;24:267-9.
20. Elliott C, Newman N, Madan A. Gentamicin effects on urinary electrolyte excretion in healthy subjects. Clin Pharmacol Ther 2000;67:16-21.
21. Hebert SC. Bartter syndrome. Curr Opin Nephrol Hypertens 2003;12:527-32.
22. Jamison RL, Ross JC, Kempson RL, et al. Surreptitious diuretic ingestion and pseudo-Bartter's syndrome. Am J Med 1982;73:142-7.
23. Shah GM, Kirschenbaum MA. Renal magnesium wasting associated with therapeutic agents. Miner Electrolyte Metab 1991;17:58-64.
24. Roediger WE, Ludwin D, Hinder RA. Hypocalcaemic response to streptomycin in malignant hypercalcaemia. Post-grad Med J 1975;51:399-401.
25. Howard M, Frizzell RA, Bedwell DM. Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations. Nat Med 1996;2:467-9.
26. Watanabe S, Fukumoto S, Chang H, et al. Association between activating mutations of calcium-sensing receptor and Bartter's syndrome. Lancet 2002;360:692-4.
27. Brown EM, MacLeod RJ. Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 2001;81:239-97.
28. Riccardi D, Hall AE, Chattopadhyay N, et al. Localization of the extracellular Ca2+/polyvalent cation-sensing protein in rat kidney. Am J Physiol 1998;274:611-22.
29. Desfleurs E, Wittner M, Simeone S, et al. Calcium-sensing receptor: regulation of electrolyte transport in the thick ascending limb of Henle's loop. Kidney Blood Press Res 1998;21:401-12.
30. Hebert SC. Extracellular calcium-sensing receptor: implications for calcium and magnesium handling in the kidney. Kidney Int 1996;50:2129-39.
31. 2+ uptake in mouse distal convoluted tubule cells. Can J Physiol Pharmacol 2000;78:595-602.